Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

McCann Health New York Lands Chief Creative Officer

June Laffey was appointed to the new position of Executive Vice President, Chief Creative Officer, McCann Health New York.

Read More »

China’s illegal opioids enter U.S. through Postal Service gaps: probe

Illegal shipments of the powerful and addictive opioid fentanyl are pouring into the United States by mail from China.

Read More »

Spark licenses blindness gene therapy rights outside U.S.

Spark Therapeutics licensed rights to its breakthrough gene therapy Luxturna outside the United States to Switzerland-based Novartis.

Read More »

AI Biotech Startup XtalPi Scores $15 Million From Google, Tencent and Sequoia

The use of artificial intelligence to address health concerns is a growing field and tech giant Google is backing Chinese company XtalPi Inc. in its goal of using AI to help with drug design.

Read More »

Top Trends Impacting Biopharma Innovation Strategy in 2018

The biopharma industry is perceived to be at a turning point, where companies have the opportunity to meaningfully adapt their innovation strategy and take advantage of major technological advances and new therapeutic modalities.

Read More »

Gates backs Central America malaria elimination plan with $31 million

Philanthropist Bill Gates’ fund is aimed at wiping out the disease in seven of the region’s countries and the Dominican Republic.

Read More »

Novartis says Entresto could become $5 billion a year blockbuster drug

A Novartis executive said the Swiss company’s heart failure medicine Entresto could be used more widely in the future.

Read More »

Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan/MabThera

Pfizer Inc. announced that REFLECTIONS B3281006, a comparative safety and efficacy study of PF-05280586 versus MabThera (rituximab-EU), met its primary endpoint.

Read More »

Europe unlikely to OK Puma breast cancer drug

Puma Biotechnology Inc. said a European regulatory panel indicated it was unlikely to provide a positive opinion on the company’s breast cancer drug.

Read More »

McCann Health Appoints New Global COO

McCann Health announced the appointment of Linda Szyper to the new position of Global Chief Operating Officer.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom